Thus, more efforts are necessary to elucidate the roles of PIRH2 and COP1 in the context of different cancers and p53 genotypes, which would be informative for the development of cancer therapies by targeting the two RING-finger E3 ligases. This evidence concerns the gene COP1 and cancer.